Idera Pharmaceuticals Inc (IDRA) stock has gained 114.89% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy. InvestorsObserver’s proprietary ranking system, gives IDRA stock a score of 93 out of a possible 100.
That rank is primarily influenced by a long-term technical score of 99. IDRA's rank also includes a short-term technical score of 97. The fundamental score for IDRA is 84. In addition to the average rating from Wall Street analysts, IDRA stock has a mean target price of 7.5. This means analysts expect the stock to climb 85.64% over the next 12 months.
What's Happening with IDRA Stock Today
Idera Pharmaceuticals Inc (IDRA) stock is down -5.16% while the S&P 500 has gained 0.39% as of 11:39 AM on Monday, Nov 23. IDRA is lower by -$0.22 from the previous closing price of $4.26 on volume of 423,942 shares. Over the past year the S&P 500 has gained 13.97% while IDRA has gained 114.89%. IDRA lost -$2.80 per share in the over the last 12 months.
Click Here to get the full Stock Score Report on Idera Pharmaceuticals Inc (IDRA) Stock.
